Jeffrey Weiland, DPM
Foot & Ankle Surgery · Pensacola, FLNPI 1528326725
Payments from drug & device makers
Across 225 payments — averaging $44.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Orthofix Medical, Inc.$5K
- Paratek Pharmaceuticals, Inc.$1K
- Smith+Nephew$667
- Musculoskeletal Transplant Foundation Inc.$308
- Johnson & Johnson$278
- AbbVie$271
- plus $3K from 28 others
What the payments were for
- Consulting fees$3504%
- Travel & lodging$3,58936%
- Food & beverage$6,02260%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Orthofix Medical, Inc. | 39 | $4,665 |
| Paratek Pharmaceuticals, Inc. | 49 | $1,195 |
| Smith+Nephew | 42 | $667 |
| Musculoskeletal Transplant Foundation Inc. | 5 | $308 |
| Johnson & Johnson(2 entities) | 7 | $278 |
| AbbVie(2 entities) | 13 | $271 |
| Tactile Systems Technology Inc | 6 | $266 |
| Reprise Biomedical, Inc. | 1 | $250 |
| Sanara Medtech Inc. | 2 | $223 |
| KCI USA, Inc. | 9 | $206 |
| Acell, Inc. | 7 | $204 |
| Solventum Corporation | 6 | $195 |
| Nevro Corp. | 2 | $164 |
| Axogen | 2 | $125 |
| Restor3d, Inc. | 1 | $103 |
| Bioventus LLC | 2 | $96 |
| Melinta Therapeutics, LLC | 4 | $76 |
| Stryker | 1 | $76 |
| Organogenesis Inc. | 3 | $75 |
| Integra Lifesciences Corporation | 4 | $73 |
| Urgo Medical North America, LLC | 5 | $71 |
| Bsn Medical Inc | 2 | $69 |
| Checkpoint Surgical, Inc | 2 | $51 |
| Stimlabs LLC | 1 | $33 |
| Avita Medical Americas, LLC | 1 | $32 |
| Convatec Inc. | 1 | $29 |
| Aroa Biosurgery Incorporated | 1 | $27 |
| Kerecis Limited | 1 | $26 |
| Cardiovascular Systems Inc. | 1 | $24 |
| Averitas Pharma Inc. | 1 | $23 |
| Reddress USA, Inc. | 1 | $18 |
| Hartmann USA, Inc. | 1 | $16 |
| Osiris Therapeutics Inc. | 1 | $13 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TrueLok$3,291
- Calcaneal Minifixator$350
- NUZYRA$331
- TL-HEX$300
- TrueLok Ring Fixation System$300
- MIRO3D$250
- Flexitouch Plus$215
- Ankle Compression Nail (ACN)$168
- CellerateRx$153
- Omnia$121
- Entre Plus$111
- AxoGuard Nerve Protector$109
- AxoGuard Nerve Connector$109
- TL-HEX TRUELOK HEXAPOD SYSTEM$108
- BME NITINOL CONTINUOUS COMPRESSION IMPLANTS$107
- ENTRE$104
How this compares
$9,961 in reported general payments places this provider in the 75th percentile of 850 foot & ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Daptomycin | 16 | $13,287 |
| SantylCollagenase Clostridium Hist. | 17 | $9,048 |
| Clindamycin Hcl | 41 | $787 |
| Doxycycline Monohydrate | 30 | $588 |
| Doxycycline Hyclate | 56 | $588 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 36 | $536 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 52 | $446 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $297 |
| Gabapentin | 14 | $214 |
| Oxycodone Hcl | 26 | $104 |
| Sodium Chloride0.9 % Sodium Chloride | 13 | $60 |
| Tramadol Hcl | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $667 | $9,04817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 850 foot & ankle surgery providers in Florida.
Other foot & ankle surgery in Pensacola
- Victor NwosuPensacola$56K
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1.1M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$938K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$814K
- Riquel GonzalezHialeah$612K
- Mario CalaHialeah$544K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.